ライフサイエンスコーパス: acute renal failure

1 n into toxic products that ultimately causes acute renal failure.

2 ic or end-stage renal disease, and seven had acute renal failure.

3 li infection is a leading cause of pediatric acute renal failure.

4 (IRI), which is the major cause of intrinsic acute renal failure.

5 nfarction, diabetes, sepsis, and hepatic and acute renal failure.

6 n of xenon before renal ischemia can prevent acute renal failure.

7 iitis, resulting in pulmonary hemorrhage and acute renal failure.

8 pathogen that causes hemorrhagic colitis and acute renal failure.

9 US is similar to TTP, but is associated with acute renal failure.

10 thic hemolytic anemia, thrombocytopenia, and acute renal failure.

11 mber of new therapies are in development for acute renal failure.

12 y provide a breakthrough in the treatment of acute renal failure.

13 eins, cyclophilin, attenuated sepsis-induced acute renal failure.

14 y and apoptotic insult during sepsis-induced acute renal failure.

15 athophysiology, prevention, and treatment of acute renal failure.

16 Attempts have been made to clearly define acute renal failure.

17 erular cells and is the most common cause of acute renal failure.

18 ons, are associated with a high incidence of acute renal failure.

19 urrent infection, cardiovascular events, and acute renal failure.

20 eday offer the best option for recovery from acute renal failure.

21 olestatic liver diseases and the associating acute renal failure.

22 l animal models during or after the onset of acute renal failure.

23 of stem cell research might be used to treat acute renal failure.

24 promise for the proactive treatment of human acute renal failure.

25 a on current and promising new therapies for acute renal failure.

26 of IL-6 was investigated in murine ischemic acute renal failure.

27 thy, hemolytic anemia, thrombocytopenia, and acute renal failure.

28 6, and this IL-6 exacerbates ischemic murine acute renal failure.

29 ded clues towards accelerating recovery from acute renal failure.

30 ators of tissue damage in ischemic and toxic acute renal failure.

31 ay be useful for cell replacement therapy of acute renal failure.

32 es renal I/R injury and severity of ischemic acute renal failure.

33 ion injury (I/R injury) is a common cause of acute renal failure.

34 ated with several renal syndromes, including acute renal failure.

35 is common, and in some cases, can present as acute renal failure.

36 herapy; the most common of these effects was acute renal failure.

37 nfection, bleeding or transfusion event, and acute renal failure.

38 d a 2.5- to 4-fold higher risk of developing acute renal failure.

39 tor antagonist was associated with decreased acute renal failure.

40 d by hemolytic anemia, thrombocytopenia, and acute renal failure.

41 enia, microangiopathic hemolytic anemia, and acute renal failure.

42 ) infections are leading causes of pediatric acute renal failure.

43 y diarrhea with the potential to progress to acute renal failure.

44 alkalinization, and monitoring for signs of acute renal failure.

45 l hemorrhage (1.6% versus 0.2%; P=0.03), and acute renal failure (13.9% versus 9.4%; P=0.02) were sig

46 7%), paraplegia (8.5%), bowel ischemia (7%), acute renal failure (21%), dialysis requirement (13%), a

47 related to treatment), pneumonia (27 [11%]), acute renal failure (25 [10%]; five related to treatment

48 omial infections (43% vs. 57%, p = .16), and acute renal failure (26% vs. 18%, p = .34).

49 (7 vs. 3), variceal hemorrhage (5 vs. 8), or acute renal failure (3 vs. 2).

50 The most common complication was acute renal failure (30.44% of cases).

51 rculatory support-related complications were acute renal failure 41%, bleeding 25%, neurologic damage

52 The most common serious adverse events were acute renal failure (41 [3.2%] vs 33 [2.5%]) and suprave

53 troke (14 [2.0%] and 15 [2.2%], P=0.79), and acute renal failure (42 [6.1%] and 35 [5.1%], P=0.45).

54 of death (2.3%, 0.8%, and 0.6%; P = .02) and acute renal failure (6.2%, 7.6%, and 2.4%; P < .001) aft

55 N1 influenza (8%), respiratory failure (8%), acute renal failure (7%), and acute respiratory distress

56 One example is acute renal failure, a major cause of morbidity and mort

57 uals, leading to life-threatening anemia and acute renal failure across endemic areas.

58 r than ischemic or multifactorial) origin of acute renal failure, acute respiratory failure, and lowe

59 Acute renal failure (adjusted odds ratio [AOR], 3.01; 95

60 living donor kidney recipients who developed acute renal failure after exposure to sirolimus-tacrolim

61 eperfusion (I/R) injury is a common cause of acute renal failure after kidney transplantation.

62 Y720 reduced IRI and prevented unrecoverable acute renal failure after significant ischemic injury.

63 protect against or accelerate recovery from acute renal failure after the renal insult.

64 This degree of acute renal failure also increased length of stay by nea

65 syndrome (D+HUS) is the most common cause of acute renal failure among children.

66 A total of 101 patients (95.3%) had acute renal failure and 78 (73.6%) required renal replac

67 ns (eg, myocardial infarction, pneumonia, or acute renal failure and a length of stay >75th percentil

68 ns (eg, pneumonia, myocardial infarction, or acute renal failure and a length of stay >75th percentil

69 y diarrhea with the potential to progress to acute renal failure and central nervous system complicat

70 part D; two adverse events leading to death (acute renal failure and death, cause unknown) were possi

71 ning also results in hyperoxaluria promoting acute renal failure and frequently death.

72 isk of postcolonoscopy complications such as acute renal failure and GI bleeding, especially in patie

73 e identified as independent risk factors for acute renal failure and GI bleeding.

74 iations were strongest between ED visits for acute renal failure and heat waves defined by maximum ap

75 fusion injury (IRI) is a feature of ischemic acute renal failure and it impacts both short- and long-

76 This study examines the incidence of acute renal failure and its associated mortality and mor

77 hip between year of surgery and diagnosis of acute renal failure and mortality.

78 for these patients to prevent or ameliorate acute renal failure and reduce the need for RRT postoper

79 rhoea and urinary sepsis in one patient, and acute renal failure and respiratory failure in one patie

80 y well tolerated, with similar occurrence of acute renal failure and treatment-emergent serious adver

81 with significant protection from I/R-induced acute renal failure and tubular damage.

82 ts (pneumonia, myelodysplastic syndrome, and acute renal failure) and two in the treatment of physici

83 at care for a larger number of patients with acute renal failure, and black patients had lower in-hos

84 smoking, steroid, congestive heart failure, acute renal failure, and dyspnea) were analyzed in terms

85 acheitis, encephalopathy, bacteremia/sepsis, acute renal failure, and myocarditis were rare (each </=

86 in-hospital events (death, stroke, bleeding, acute renal failure, and need for permanent pacemaker) w

87 nervous system, leading to bloody diarrhea, acute renal failure, and neurological complications.

88 el disease, critical illness, liver failure, acute renal failure, and organ transplantation.

89 opathy, adult respiratory distress syndrome, acute renal failure, and sepsis.

90 Renal ischemia-reperfusion injury causes acute renal failure, and the hallmarks of renal ischemia

91 imately 50%), ileus ( approximately 2 days), acute renal failure ( approximately 30%), and blood loss

92 The risk of mortality associated with acute renal failure (ARF) after open-heart surgery conti

93 ims databases may be useful for the study of acute renal failure (ARF) and ARF that requires dialysis

94 Sepsis is a major cause of acute renal failure (ARF) and death.

95 Ischemia reperfusion injury leading to acute renal failure (ARF) and delayed graft function is

96 R) injury of the kidney is a common cause of acute renal failure (ARF) and is associated with high mo

97 Kidneys from deceased donors with acute renal failure (ARF) are generally not accepted for

98 Acute renal injury (ARI) and acute renal failure (ARF) are serious complications afte

99 the incidence and prognostic implications of acute renal failure (ARF) are unknown.

100 nown that, among human patients with sepsis, acute renal failure (ARF) dramatically increases mortali

101 Patients with acute renal failure (ARF) experience a high mortality ra

102 The long-term effects of ischemic acute renal failure (ARF) following uninephrectomy are u

103 Acute renal failure (ARF) has high mortality and no effe

104 e prediction of adverse clinical outcomes in acute renal failure (ARF) has not been well described.

105 have concluded that outcomes associated with acute renal failure (ARF) have not improved significantl

106 to determine the incidence and mortality of acute renal failure (ARF) in Medicare beneficiaries.

107 ported that rapamycin impairs recovery after acute renal failure (ARF) in rats.

108 nd to bovine serum albumin ameliorate murine acute renal failure (ARF) induced by temporary occlusion

109 Acute renal failure (ARF) is a common life-threatening c

110 Acute renal failure (ARF) is a syndrome that occurs when

111 Clinical studies demonstrate that acute renal failure (ARF) is associated with increased m

112 Progress in treating human acute renal failure (ARF) is dependent on developing tec

113 kidneys recovered from deceased donors with acute renal failure (ARF) is higher compared with those

114 ration (CVVHDF) on survival in patients with acute renal failure (ARF) is unknown.

115 The mortality rate for patients with acute renal failure (ARF) remains unacceptably high.

116 We therefore hypothesized that LPS-induced acute renal failure (ARF) requires systemic TNF release

117 Acute renal failure (ARF) secondary to ischemic injury r

118 Acute renal failure (ARF) sensitizes the kidney to endot

119 Acute renal failure (ARF) seriously worsens prognosis of

120 Treatment of acute renal failure (ARF) would be enhanced by identific

121 The most prevalent complications were acute renal failure (ARF)(24.2%), septicemia (18.2%), an

122 Acute renal failure (ARF), characterized by sudden loss

123 ction of postoperative 180-day mortality and acute renal failure (ARF), improving upon predictions th

124 Acute renal failure (ARF), recently renamed acute kidney

125 Acute renal failure (ARF), resulting from ischemic or to

126 Among the 31 patients, 21 presented with acute renal failure (ARF), were normocalcemic, and had a

127 species are important mediators of injury in acute renal failure (ARF).

128 nt of cellular damage after ischemia-induced acute renal failure (ARF).

129 osis occurs in the kidney during LPS-induced acute renal failure (ARF).

130 in sepsis, a condition often accompanied by acute renal failure (ARF).

131 can cause bloody diarrhea and, occasionally, acute renal failure as a consequence of Shiga toxin (Stx

132 tested the hypothesis that the diagnosis of acute renal failure associated with coronary artery bypa

133 We conclude that the nationwide trend of acute renal failure associated with coronary artery bypa

134 EPO can ameliorate ischaemic and nephrotoxic acute renal failure, Bahlmann's work is the first eviden

135 a novel therapeutic intervention in ischemic acute renal failure, based at least in part on its abili

136 In stratified analyses of patients with acute renal failure, black patients had significantly lo

137 rest, coma >24 hours, myocardial infarction, acute renal failure, bleeding requiring >4 units of red

138 Many show promise in animal models of acute renal failure but prospective studies in humans ar

139 udy, the role of exogenous HGF in preventing acute renal failure by systemic administration of naked

140 ation for >=48 hours (c-statistic 0.86), and acute renal failure (c-statistic 0.85).

141 % (95% confidence interval [CI], 67%-91%) of acute renal failure cases compared with 38% (95% CI, 25%

142 The proportion of acute renal failure cases that required dialysis decreas

143 Acute renal failure causes considerable morbidity and mo

144 isease, the incidence of secondary causes of acute renal failure continue to grow, especially in pati

145 Acute renal failure continues to complicate the postoper

146 s grafted into WT recipients (n=7) developed acute renal failure (control group), WT grafts transplan

147 mposite of mortality, myocardial infarction, acute renal failure, coronary revascularization, or stro

148 Incidence of acute renal failure decreased in the PBM cohort (2.39% v

149 30 mL/min who received a high dose of GBCA, acute renal failure, delayed hemodialysis after contrast

150 Acute renal failure developing after orthotopic liver tr

151 The incidence of acute renal failure diagnosis increased significantly du

152 ndings suggest that the observed increase in acute renal failure diagnosis rates may be partly attrib

153 ttributable to less restrictive criteria for acute renal failure diagnosis, consistent with acute ren

154 further assess the role of BAK in sepsis in acute renal failure, dogs were nephrectomized and 48 h l

155 5) on deviant days for heat-related illness, acute renal failure, electrolyte imbalance, and nephriti

156 tions, particularly in splenectomized cases, acute renal failure, Evans syndrome, and multitreatment

157 reased susceptibility to hospitalization for acute renal failure for blacks, Hispanics, people aged 2

158 Acute renal failure frequently occurs in the intensive c

159 Acute renal failure from both ischemia and contrast are

160 eceived N-acetylcysteine had an incidence of acute renal failure (>or=0.5 mg/dL increase in creatinin

161 diffuse neurologic deficit, amaurosis fugax, acute renal failure, gut ischemia, livedo reticularis an

162 Depending on the definition used, acute renal failure has been reported to affect from 1%

163 The therapy of acute renal failure has changed substantially during the

164 The scarcity of early biomarkers for acute renal failure has hindered our ability to launch p

165 A precise biochemical definition of acute renal failure has never been proposed, and until r

166 ology and insight into mechanisms leading to acute renal failure have triggered investigators to eval

167 luded congenital heart disease, age >/=1 yr, acute renal failure, hepatic insufficiency, and sepsis.

168 Secondary endpoints included acute renal failure, hyperkalemia, the prevalence of hyp

169 Preventing acute renal failure, improving clinical outcomes of the

170 ADV nephritis was associated with acute renal failure in 90% of the infected patients.

171 SC reduced the severity of cisplatin-induced acute renal failure in adult female mice.

172 yndrome, which is the most frequent cause of acute renal failure in children in the Americas and Euro

173 ome (HUS), which is the most common cause of acute renal failure in children in the United States.

174 erichia coli and is the most common cause of acute renal failure in children.

175 chia coli infection, is the leading cause of acute renal failure in children.

176 auses of hemolytic uremic syndrome (HUS) and acute renal failure in children.

177 c syndrome (HUS) is the most common cause of acute renal failure in children.

178 IAH/ACS is an important possible cause of acute renal failure in critically ill patients and scree

179 se events have failed to alter the course of acute renal failure in human trials.

180 c syndrome (HUS) is the most common cause of acute renal failure in infants and young children, and i

181 We studied acute renal failure in patients hospitalized between 200

182 here were trends toward reduced incidence of acute renal failure in patients with baseline Sequential

183 Trends toward reduced incidence of acute renal failure in patients with baseline SOFA score

184 c glomerulonephritis (TGN), a known cause of acute renal failure in patients.

185 Ideal care for women with acute renal failure in pregnancy or postpartum requires

186 our understanding of the pathophysiology of acute renal failure in pregnancy where plasma androgen l

187 ing the frequency of acute kidney injury and acute renal failure in the critically ill.

188 replacement therapy over the past few years, acute renal failure in the intensive care unit remains a

189 s, the most common condition associated with acute renal failure in the intensive care unit, may alte

190 udies have suggested a variable incidence of acute renal failure in this population, with an associat

191 Nonhematologic toxicity was grade 3 acute renal failure in two patients; grade 3 electrolyte

192 hagic Escherichia coli is the major cause of acute renal failure in young children.

193 Acute renal failure is a common complication in critical

194 Acute renal failure is a rare complication of pregnancy

195 Acute renal failure is associated with high mortality an

196 Acute renal failure is characterized by an increase in t

197 racial differences exist in mortality after acute renal failure is not known.

198 nces in understanding the pathophysiology of acute renal failure, little progress has been made in it

199 The incidence of acute renal failure may be increasing and the mortality

200 pment of sensitive, predictive biomarkers of acute renal failure may help to diagnose the syndrome ea

201 Secondary outcomes included encephalopathy, acute renal failure, mechanical ventilation, and dischar

202 (n = 2), gastric outlet obstruction (n = 1), acute renal failure (n = 2), pneumonia (n = 2), respirat

203 possible exception of radio-contrast-induced acute renal failure, no drugs are capable of preventing

204 Acute renal failure occurred in 15 (58%) of 26 patients.

205 Acute renal failure occurs frequently in hospitalized pa

206 scitation on multivariable analysis included acute renal failure (odds ratio 1.5, 95% confidence inte

207 io 36.6, 95% confidence interval 21.9-61.0), acute renal failure (odds ratio 21.6, 95% confidence int

208 ly associated with clinical failure included acute renal failure (odds ratio [OR], 3.91 [95% confiden

209 ppears to be the initiating event behind the acute renal failure of familial HUS patients.

210 ted with high rates of in-hospital death and acute renal failure, often requiring dialysis.

211 The impact of acute renal failure on mortality, length of stay, and ch

212 rate (eGFR) lower than 30 mL/min, and 11 had acute renal failure or acute deterioration of chronic re

213 inflammatory state, more specific effects of acute renal failure or chronic kidney disease, and effec

214 onged ventilation), and renal complications (acute renal failure or insufficiency).

215 en expended to develop techniques to prevent acute renal failure or to facilitate its resolution.

216 th (OR 7.8, 95% CI 4.2 to 14.7; p < 0.0001), acute renal failure (OR 2.8, 95% CI 1.4 to 5.7; p = 0.00

217 y (OR, 8.6; 95% CI, 3.9-18.8; P < .001), and acute renal failure (OR, 10.5; 95% CI, 3.8-29.3; P < .00

218 mia (OR, 9.03; 95% CI, 3.49-23.38; P<0.001), acute renal failure (OR, 3.61; 95% CI, 1.68-7.75; P=0.00

219 hromboembolism (OR:2.11; 95% CI: 1.70-2.61), acute renal failure (OR: 1.34; 95% CI; 1.22-1.47), and s

220 peracillin" and "tazobactam"] and ["AKI" or "acute renal failure" or "nephrotoxicity"] and registered

221 peracillin" and "tazobactam"] and ["AKI" or "acute renal failure" or "nephrotoxicity"] and registered

222 ents with a subarachnoid hemorrhage, trauma, acute renal failure, or severe community-acquired pneumo

223 rbidities except for dialysis (P = 0.07) and acute renal failure (P = 0.19).

224 e (P<0.0001), need for laparotomy (P<0.008), acute renal failure (P<0.0001), need for dialysis (P<0.0

225 ute renal failure diagnosis, consistent with acute renal failure patterns observed in other clinical

226 l 9% increase in odds of hospitalization for acute renal failure per 5 degrees F (2.78 degrees C) was

227 nts that were deemed unrelated to alectinib: acute renal failure; pleural effusion and pericardial ef

228 k for postoperative complications, including acute renal failure, pneumonia, bleeding, septicemia, st

229 Notably, acute renal failure predicted worse outcomes and perform

230 tive risk, 1.42; P<0.001), and postoperative acute renal failure (relative risk, 2.13; P<0.001).

231 Mortality rates in acute renal failure remain extremely high, and risk-adju

232 Despite declining mortality, acute renal failure remains a burden on healthcare resou

233 Acute tubular necrosis secondary to ischemic acute renal failure remains a common clinical problem wi

234 Acute renal failure remains a common complication of non

235 Acute renal failure remains a major complication of coro

236 Acute renal failure remains a significant cause of morbi

237 19%), cardiac arrest (10%), sepsis (7%), and acute renal failure requiring dialysis (3%).

238 ents for each sample was 2% (39 of 1924) for acute renal failure requiring dialysis, 0.7% (18 of 2327

239 Similarly, among those with acute renal failure requiring dialysis, black patients h

240 Postoperative occurrences of acute renal failure requiring dialysis, deep vein thromb

241 He developed seizures and acute renal failure requiring intubation and plasma exch

242 Acute renal failure requiring renal replacement therapy

243 Only mechanical ventilation days and acute renal failure requiring renal replacement therapy

244 Acute renal failure requiring renal replacement therapy

245 ute respiratory distress syndrome (ARDS) and acute renal failure, requiring mechanical ventilation, v

246 replaced the terms chronic renal failure and acute renal failure, respectively.

247 enal solid organ transplants are at risk for acute renal failure resulting from cardiac or hepatic fa

248 Acute renal failure resulting from hypoperfusion and hyp

249 Acute renal failure results in significant morbidity and

250 (RR=12.17 [95% CI 1.3-117.2], P=0.007), and acute renal failure (RR=11.8 [95% CI 2.9-48.8], P<0.001)

251 Acute renal failure secondary to ischemic injury remains

252 se, presenting with profound hypotension and acute renal failure, secondary to hypovolemic shock.

253 , including myocardial infarction, diabetes, acute renal failure, sepsis, and acute lung injury.

254 s associated with failure to rescue included acute renal failure, septic shock, and postoperative pul

255 ncluded bacteremia, pulmonary complications, acute renal failure, shock, intensive care unit admissio

256 of diuretics in critically ill patients with acute renal failure should be discouraged.

257 performance metrics to six generic and four acute renal failure-specific predictive models.

258 placement therapy) to $876,539 (data from an acute renal failure study in which continuous renal repl

259 in comorbid disease burden, mortality in the acute renal failure subgroup declined from 39.5% to 17.9

260 The percentage of acute renal failure survivors with postdischarge special

261 one (0.7%) group were less likely to develop acute renal failure than those randomized to placebo (5.

262 l mortality is lower for black patients with acute renal failure than white patients.

263 Five additional patients with acute renal failure that was caused by cast nephropathy

264 We found no increase in the incidence of acute renal failure, the frequency of intensive care uni

265 herapies for the treatment and prevention of acute renal failure, there are reasons to be optimistic.

266 microvasculature by platelet-fibrin thrombi, acute renal failure, thrombocytopenia, microvascular hem

267 The patient developed acute renal failure, thrombocytopenia, transaminitis, an

268 Exclusion criteria were acute renal failure, trauma, and surgery within 2 days.

269 ow- and high-intensity treatment arms of the Acute Renal Failure Trial Network and RENAL Replacement

270 Demographic data and effluent rates from the Acute Renal Failure Trial Network and RENAL Replacement

271 The Acute Renal Failure Trial Network study evaluated 1,124

272 The Acute Renal Failure Trial Network study was a multicente

273 of death, myocardial infarction, stroke, or acute renal failure up to the time of hospital discharge

274 a relatively clear benchmark for diagnosing acute renal failure, use of alternate criteria to define

275 ife-threatening disease often accompanied by acute renal failure, usually occurs after gastrointestin

276 lung transplant recipients, the incidence of acute renal failure was 25%, with 8% of patients requiri

277 Index acute renal failure was associated with increased odds o

278 The incidence of acute renal failure was higher among KT patients (40.9%

279 Acute renal failure was induced by 5 mg/kg subcutaneous

280 Rhabdomyolysis-induced acute renal failure was induced in mice by glycerol inje

281 =7), where the protection from postoperative acute renal failure was no greater than in mice with MAS

282 In the latter patient, acute renal failure was not suspected to be related to e

283 ients who did not require renal replacement, acute renal failure was strongly associated with increas

284 ative pathway, to protect mice from ischemic acute renal failure was tested.

285 eptor activity is required for recovery from acute renal failure, we examined the role of the EGF rec

286 esult of diabetic nephropathy presented with acute renal failure, weakness, myalgia, and pigmented ur

287 Three main outcomes related to acute renal failure were analyzed: the need for renal re

288 ry failure, major cardiac complications, and acute renal failure were associated with an increased mo

289 tus, congestive heart failure, or chronic or acute renal failure were identified as high-risk patient

290 dothelial injury, glomerular thrombosis, and acute renal failure were markedly attenuated despite the

291 , septicemia, acute respiratory failure, and acute renal failure were the most common causes for read

292 The NSF incidence in the patients with acute renal failure who received a high dose when their

293 h no-balanced fluids: in-hospital mortality, acute renal failure with and without dialysis, and hospi

294 pio) developed thrombocytopenia, anemia, and acute renal failure with loss of glomerular function, in

295 ed by hemolytic anemia, thrombocytopenia and acute renal failure with multiple organ involvement.

296 its contribution to acute kidney injury and acute renal failure with regard to intra-abdominal press

297 significant differences in the prevalence of acute renal failure (with and without dialysis) or in-ho

298 nia, dehydration, heat stroke, diabetes, and acute renal failure, with a 10 degrees F increase in sam

299 of a pathogenic role for B cells in ischemic acute renal failure, with a serum factor as a potential

300 a, approximately 10% have dialysis-dependent acute renal failure, with cast nephropathy, caused by mo